The EurA1c study reviewed nine years of external quality assessment (EQA) data from up to 5,120 laboratories across 29 countries, providing one of the most comprehensive evaluations of HbA1c testing performance worldwide.
The results demonstrate that HbA1c measurement has achieved a high level of standardization and stable analytical performance over the last decade. At the same time, the study highlights that differences between countries and manufacturers still exist, emphasizing the ongoing importance of quality assurance and method performance assessment.
These findings reinforce the value of participating in EQA programs and selecting HbA1c methodologies that consistently deliver accurate and reliable results to support both diabetes diagnosis and long-term patient management. The long-term performance data also illustrate the ability of several manufacturer platforms, including Sebia systems, to maintain high analytical quality within large-scale international EQA programs.
Test associated with this resource
Related instruments
コンパクトかつ導入しやすい全自動キャピラリー電気泳動システム
進化が違いを生む
Sebiaの専門知識を結集した高スループット装置。
Discover more resources on Diabetes
電気泳動装置で実施されるSebia検査のための包括的なデータ解析・判読支援ソフトウェア。
このセクションには広く一般に公開されることを目的とした情報が含まれており、そのため、お住まいの国では入手できない、または有効でない製品の詳細や情報が含まれている可能性があります。お近くのSebia担当者にお問い合わせください。医療従事者向けの情報です。試薬の添付文書および機器の取扱説明書の指示を注意深くお読みください。